ST Germain D J Co. Inc. Sells 2,459 Shares of CME Group Inc. (NASDAQ:CME)

ST Germain D J Co. Inc. reduced its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 8.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 26,818 shares of the financial services provider's stock after selling 2,459 shares during the quarter. ST Germain D J Co. Inc.'s holdings in CME Group were worth $5,917,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the business. B. Riley Wealth Advisors Inc. grew its holdings in shares of CME Group by 1.3% during the 4th quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider's stock worth $782,000 after acquiring an additional 48 shares during the period. Perpetual Ltd boosted its holdings in shares of CME Group by 30.5% during the 1st quarter. Perpetual Ltd now owns 3,622 shares of the financial services provider's stock valued at $780,000 after buying an additional 846 shares in the last quarter. Park Avenue Securities LLC grew its position in shares of CME Group by 2.8% in the 1st quarter. Park Avenue Securities LLC now owns 14,380 shares of the financial services provider's stock worth $3,096,000 after buying an additional 392 shares during the period. MJP Associates Inc. ADV bought a new stake in CME Group during the first quarter worth about $243,000. Finally, Salem Investment Counselors Inc. increased its stake in shares of CME Group by 67.1% during the first quarter. Salem Investment Counselors Inc. now owns 234 shares of the financial services provider's stock valued at $50,000 after purchasing an additional 94 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, Director Bryan T. Durkin sold 7,593 shares of the company's stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on CME shares. Bank of America boosted their price target on CME Group from $177.00 to $180.00 and gave the stock an "underperform" rating in a research report on Thursday, October 3rd. Morgan Stanley upped their price target on shares of CME Group from $210.00 to $233.00 and gave the stock an "equal weight" rating in a research note on Thursday. Deutsche Bank Aktiengesellschaft raised their price objective on shares of CME Group from $193.00 to $200.00 and gave the company a "hold" rating in a research note on Thursday, August 15th. Piper Sandler lifted their target price on shares of CME Group from $225.00 to $240.00 and gave the stock an "overweight" rating in a report on Tuesday, October 8th. Finally, JPMorgan Chase & Co. raised their price target on shares of CME Group from $187.00 to $191.00 and gave the company an "underweight" rating in a research report on Thursday, July 25th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $220.07.

CME Group Stock Performance

Shares of CME traded up $1.09 on Friday, reaching $228.32. The company's stock had a trading volume of 1,203,010 shares, compared to its average volume of 1,941,867. The stock's 50 day simple moving average is $216.92 and its two-hundred day simple moving average is $208.34. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $82.21 billion, a P/E ratio of 25.97, a PEG ratio of 7.76 and a beta of 0.55. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $230.12.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping the consensus estimate of $2.53 by $0.03. The business had revenue of $1.53 billion for the quarter, compared to analysts' expectations of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company's revenue was up 12.7% compared to the same quarter last year. During the same quarter last year, the company posted $2.30 EPS. Research analysts forecast that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were given a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.01%. CME Group's payout ratio is currently 52.33%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.